NDC11 87063028812
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 87063-0288-12 | 87063-0288 |
| 87063-288-12 | 87063-288 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| naratriptan | NARATRIPTAN | ASCLEMED USA INC. | 63ea356f-0895-4540-b242-8e611eacd938 | 2026-08-07 | Warnings, Adverse reactions | 87063-288-12 87063-288 87063028812 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.